Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
about
Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitisFacile synthesis of an up-conversion luminescent and mesoporous Gd2O3 : Er3+@nSiO2@mSiO2 nanocomposite as a drug carrier.Poly(acrylic acid)-modified Fe3O4 microspheres for magnetic-targeted and pH-triggered anticancer drug delivery.Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.Highly flexible and nonflammable inorganic hydroxyapatite paper.Uniform iron oxide hollow spheres for high-performance delivery of insoluble anticancer drugs.Phase stability and biological property evaluation of plasma sprayed hydroxyapatite coatings for orthopedic and dental applications.Europium-doped amorphous calcium phosphate porous nanospheres: preparation and application as luminescent drug carriers.The effect of temozolomide/poly(lactide-co-glycolide) (PLGA)/nano-hydroxyapatite microspheres on glioma U87 cells behaviorRandomized controlled clinical trial of 2 types of hydroxyapatite-coated implants on moderate periodontitis patients.Defect-related luminescent materials: synthesis, emission properties and applications.Current advances in lanthanide ion (Ln(3+))-based upconversion nanomaterials for drug delivery.In vitro labeling of hydroxyapatite minerals by an engineered protein.Evaluating the toxicity of hydroxyapatite nanoparticles in catfish cells and zebrafish embryos.Preparation of pH-responsive mesoporous hydroxyapatite nanoparticles for intracellular controlled release of an anticancer drug.The inhibition of lamellar hydroxyapatite and lamellar magnetic hydroxyapatite on the migration and adhesion of breast cancer cells.Low-toxic Mn-doped ZnSe@ZnS quantum dots conjugated with nano-hydroxyapatite for cell imaging.AIE luminogen bridged hollow hydroxyapatite nanocapsules for drug delivery.Multifunctional magnetic fluorescent hybrid nanoparticles as carriers for the hydrophobic anticancer drug 5-fluorouracil.Highly stable amorphous calcium phosphate porous nanospheres: microwave-assisted rapid synthesis using ATP as phosphorus source and stabilizer, and their application in anticancer drug delivery.Fluoridated HAp:Ln3+ (Ln = Eu or Tb) nanoparticles for cell-imaging.Preparation of luminescent and mesoporous Eu3+/Tb3+ doped calcium silicate microspheres as drug carriers via a template route.Biological response of osteosarcoma cells to size-controlled nanostructured hydroxyapatite.Controlling drug delivery kinetics from mesoporous titania thin films by pore size and surface energy.Facile Synthesis, Characterization, and Cytotoxic Activity of Europium-Doped Nanohydroxyapatite.Facile and controllable synthesis of monodisperse CaF2 and CaF2:Ce3+/Tb3+ hollow spheres as efficient luminescent materials and smart drug carriers.Calcium-based biomaterials for diagnosis, treatment, and theranostics.Recent progress on fabrication and drug delivery applications of nanostructured hydroxyapatite.Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity.PNIPAAM modified mesoporous hydroxyapatite for sustained osteogenic drug release and promoting cell attachment.Deposition of luminescent Y2O3:Eu3+ on ferromagnetic mesoporous CoFe2O4@mSiO2 nanocomposites.Hydroxyapatite hierarchically nanostructured porous hollow microspheres: rapid, sustainable microwave-hydrothermal synthesis by using creatine phosphate as an organic phosphorus source and application in drug delivery and protein adsorption.Core-shell hollow microspheres of magnetic iron oxide@amorphous calcium phosphate: synthesis using adenosine 5'-triphosphate and application in pH-responsive drug delivery.Enhancing the luminescence of Eu3+ /Eu2+ ion-doped hydroxyapatite by fluoridation and thermal annealing.Hierarchical hollow hydroxyapatite microspheres: microwave-assisted rapid synthesis by using pyridoxal-5'-phosphate as a phosphorus source and application in drug delivery.Magnetic mesoporous carbonated hydroxyapatite microspheres with hierarchical nanostructure for drug delivery systemsMonodisperse CeF3, CeF3:Tb3+, and CeF3:Tb3+@LaF3 core/shell nanocrystals: synthesis and luminescent propertiesMonodisperse bifunctional Fe3O4@NaGdF4:Yb/Er@NaGdF4:Yb/Er core–shell nanoparticlesCucurbituril/hydroxyapatite based nanoparticles for potential use in theranostic applicationsHollow hydroxyapatite/polyelectrolyte hybrid microparticles with controllable size, wall thickness and drug delivery properties
P2860
Q28086953-B53AD75B-ED41-4DA5-A281-63738711A56AQ33754802-E3324536-770D-4F1C-A721-3D089FA993BDQ34451685-27768AFF-30C2-459B-9002-22216C348CD8Q34729395-78DD47DE-FE58-4B86-AA74-446F2BD4D4EEQ35079426-42507504-57AC-4A6C-877A-06FA8F46C67EQ35137690-493DB004-6DF2-4DD2-B935-6E6F67B737D9Q35413229-6079D50A-156B-4E20-9546-1CA9CD8CED43Q35538737-8F0FEDD2-295B-451C-B94B-DA4338357372Q35719594-3794F99E-181D-4443-B021-50D15D788E4DQ37373343-081F6ED3-B3BE-4BC1-9D8D-17A309441793Q38047286-D105521E-C133-46C8-9417-BF4D05E96784Q38225630-3E6C126B-7922-41B6-B9AF-09FA97250288Q38338440-A97250DA-3AC0-45CD-9B12-FA50102AD53AQ38423687-EC1FBE68-1B19-472E-979B-ED29C5B1F512Q38826492-EE1BC28D-D2C3-4186-9B28-927A6FBC6AF5Q39040959-B9B25D48-D850-4810-A70A-8FAFA421375BQ39111408-E49F6895-7E84-4069-B039-296ACE4D8FBCQ39149505-4B225169-168E-4B6F-849E-D72CD28DB850Q39235562-D5518D6A-BDB7-472F-AFD3-E3E369329895Q39238879-64F79C12-A806-42FA-A649-6F4F48E4B9F5Q39257336-D6DF6D3E-AFA4-4949-A46A-A9F8F7A4D9EFQ39616110-D9A9532F-FE0E-4746-A505-6D82C96DC599Q39804384-6BB9DD06-3F33-4451-BF5B-AA1763772D70Q40725552-DFEA8C1B-127B-463D-8631-458D89F908F6Q42150282-988F6878-04B9-4165-A92B-9EB1B27BEB27Q43099950-23D67767-D740-4EC9-90F1-982D98544CD2Q47231934-6C05C3AE-2A01-4A5E-B155-E82E74F0580EQ47368791-D6C8F9CD-4C10-4FD9-83DF-E6CB67492B47Q50234830-57319D8A-5278-4EF6-9578-FB4025A33AC6Q50249854-0B5F2FD8-682C-4432-825A-F4D01332C0E7Q50473607-8DAE1BF2-E41F-4762-83C5-D13877B4987DQ51827187-D243527F-C92B-46F1-B87A-AAE0EBA0BD4CQ53479428-37208D54-931D-40AA-8780-030AC4CC65E6Q53606892-9C973480-8317-4BBE-A095-ACB04B24D491Q54507631-88507F23-B8ED-468F-9559-BAB2FE8D5C54Q57219241-234626C1-EC96-4D65-ABEE-963DF20E4DD4Q57376451-A2258548-4889-4719-B935-E0B4F2E5F56AQ57376592-EB440FC0-DF20-4CCC-A01A-2E6434CA8CFCQ57376775-6EBE94A6-73B2-407A-8C10-5B044E9CAF05Q57756414-38C88003-AEF1-45AF-9CF9-0845E1A67F05
P2860
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
@en
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
@nl
type
label
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
@en
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
@nl
prefLabel
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
@en
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier.
@nl
P2093
P1433
P1476
Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier
@en
P2093
Chunxia Li
Hongzhou Lian
Piaoping Yang
Zewei Quan
P304
P356
10.1016/J.BIOMATERIALS.2008.07.042
P577
2008-08-19T00:00:00Z